Beraprost

DRUG2 trials

Sponsors

Toray Industries, Inc, Astellas Pharma Inc

Conditions

Renal Insufficiency, ChronicType 2 Diabetes Mellitus

Phase 2

TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

CompletedNCT02480751

Toray Industries, IncRenal Insufficiency, Chronic

Start: 2005-10-31Updated: 2015-06-29

Phase 4

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

TerminatedNCT02786979

Astellas Pharma IncType 2 Diabetes Mellitus

Start: 2010-07-31End: 2013-01-31Updated: 2016-06-21

Related Papers

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial

BMC Nephrology2015-10-1619 citations